Archive for June, 2009

What are penny stocks?

Saturday, June 20th, 2009

In U.S. financial markets, penny stocks commonly refer to any stock trading outside one of the major exchanges (NYSE, Nasdaq, or AMEX), and is often considered very risky.

In the UK, penny shares as they are more commonly called, usually refer to a stock and shares in small cap companies, which is defined as being companies with a market capitalization of less than £100 million and/or a share price of less than £1 with a bid/offer spread greater than 10 percent. In the UK Penny Shares are covered by a standard regulatory risk warning issued by the Financial Services Authority(FSA).

Trading penny stocks is the easiest way to make the large profits with the least amount of startup capital. Why? Because of their volatility. It’s a lot more difficult to find a $50 stock that goes up 100 percent in a short time, but there are hundreds of penny stocks that go from a penny to two cents, a dime to 20 cents, or a dollar to two dollars in a matter of days.

There are risks associated with trading penny stocks. In many cases these risks can be mitigated or avoided altogether, but there is always the chance of losing money.

Penny stocks have a bad name, because scammers use thinly traded shares to take advantage of people, with pump and dump schemes, and by providing manipulative information. Penny stocks also get a bad name because many investors lose money trading them, when they don’t understand what their investing in, or how to trade these penny stocks. Many people trade penny stocks before they learn about the easily avoidable dangers, and then complain that penny stocks are dangerous. However, for those investors who do learn how to find good quality companies, and take the time to understand the dangers and how to avoid them, there are tremendous profits to be made.

During a ten year period between 1993 and 2003, the growth in the volume of shares traded on the OTCBB — almost entirely comprised of penny stocks — eclipsed trading volume on the Nasdaq and NYSE (See Figure 1).

Figure 1: Volumes for the Nasdaq and OTCBB. OTCBB volume grew 8900 percent between 1993 and 2003, eclipsing both the Nasdaq (638 percent) and NYSE (512 percent) volume increases by a wide margin.

Volumes on the Pink Sheets  have grown even faster. In 1998, about 9 billion shares traded, and by 2003, volumes had surged to 187.5 billion–an incredible increase of more than 2000% in just five years. (See Figure 2).

Figure 2: Rise in trading volumes on the Pink Sheets

How do you trade penny stocks? Are there any techniques that work best?

Technical analysis that uses indicators and statistics to predict price movements is one possible approach, according to Investopedia. But due to the rampant growth of the penny stock phenomenon, technicians haven’t had the time to build a strategy–assuming anyone is interested in coming up with one. As far as analyzing sub-penny stocks, it would require a new system for charting and monitoring to determine the significance of a 0.0001-cent move, and there is no telling whether or not it would work.

Buzz Stock of the Day – Smith and Wesson (SWHC)

Friday, June 19th, 2009

Shares of Smith and Wesson Holding Corp. (Nasdaq: SWHC) ended the day 22 percent higher on eight-times the gunsmith’s average three-month volume after the company announced $99.5 million in fourth-quarter revenue. The 20 percent boost over the same period last year was above analysts’ forecast of $90.8 million, according to Thomson Reuters.

“Demand for our handguns and tactical rifles remained strong throughout the fourth quarter, as evidenced by our revenue as well as by our backlog balance,” the company said in a statement.

The company is also adding a new stream of revenue to its arsenal. On Thursday, Smith and Wesson Holding Corp. announced a deal to acquire Universal Safety Response, a privately held maker of barriers, gates and other perimeter security related equipment, for $52.5 million in cash and stock.

In a recent news release, Smith and Wesson stated that the deal should bring in revenue of $100 million next year and generate EBITDA of $15 million.

According to a recent report by the Dow Jones Newswires, first-time gun buyers, it’s been said, have rushed to buy firearms ahead of the new administration’s assumed tougher stance on gun-control laws.

The company will release full results for the quarter on June 22, after the market closes. Analysts are looking for earnings per share of 9 cents.

Buzz Stock of the Day – Carmike Cinemas (CKEC)

Friday, June 19th, 2009


Shares of Carmike Cinemas, Inc. (Nasdaq: CKEC) closed 6.6 percent higher today

On Monday, the Standard & Poor’s Ratings Service raised its outlook on the movie theater chain citing its recent box office receipts and debt reduction.

Carmike operates 250 theaters and nearly 2,300 screens in 36 states, with a focus on small and mid-sized communities.

Credit analyst Jeanne Mathewson stated in a note: “We believe that the company’s cushion of compliance could increase further if strong box office and operating performance continues.”

Earlier this year, Merriman Curhan Ford analyst Eric Wold reiterated his “Buy” rating for Carmike shares, saying that the company’s domestic box office revenues rose 9 percent to 10 percent in the first quarter despite a lineup of movies that he considered “fairly lackluster.”

We’re only in the second week of June and there are already a handful movies that have grossed more than $100 million in less than a month of being released, and many more like Star Trek, and Angels and Demons, which continue to gross big numbers despite tough competition.

Carmike was first named a Buzz Stock, when shares were trading at $3.42 a share. Loyal readers are enjoying a hefty 126 percent gain.

We’re bullish on Carmike through the end of the Summer, and we’ll keep you posted on whether we see any good trailers for movies coming out in the fall.

Click here to sign up for picks from the best newsletters on the Street. FREE!

Buzz Stock of the Day – Atlantic Tele-Network (ATNI)

Wednesday, June 10th, 2009

Shares of Atlantic Tele-Network, Inc. (Nasdaq: ATNI) were up as much as 47 percent at mid-day trading today, after the Salem-based telecommunications service provider announced a definitive agreement to acquire $200 million in certain wireless assets from Verizon Wireless.

Atlantic Tele-Network will acquire wireless properties, including wireless spectrum licenses and network assets, serving over 800,000 subscribers primarily in rural areas across Georgia, North Carolina, South Carolina, Illinois, Ohio, and Idaho. Verizon Wireless is required to divest these properties as part of the regulatory approvals granted for its purchase of Alltel earlier this year.

[–quote–]
As of April 30, 2009, Atlantic Tele-Network had approximately $90 million in cash and cash equivalents, $75 million of available borrowings under its undrawn revolving credit facility, and an additional $50 million of borrowing capacity, subject to lender consent, under its term credit facility.

Atlantic Tele-Network expects the transaction to close by Q3 or Q4 of this year.

According to CEO, Michael Prior, the acquisition provides the company with “enhanced scale and revenue diversification,” and expand its U.S. wireless business. “Coupled with our existing U.S. wireless operations, we will now have significant wireless operations in rural areas of more than 10 states. Including our international operations, we expect to have more than 1,000,000 retail wireless subscribers by transaction close.”

We like ATN because the company is relsilient, generates cash from operations, and has healthy earnings growth. Shares of ATNI are down about 8.4% in the past 52-weeks, compared to Verizon’s 21.5% drop, AT&T’s 34.9% drop and Sprint’s 42.3% drop over teh past year.

ATNI generated about $65.8 million in operating cash flow and$24.1 million of levered free cash flow in the trailing 12-month period.

Buzz Stock of the Day – GeoPharma, Inc. (GORX)

Tuesday, June 9th, 2009

Shares of GeoPharma, Inc. (Nasdaq: GORX) were up as much as 155 percent at mid-day today.

Despite a 28 percent decrease in third quarter revenues, CEO Mihir Taneja said that the company is confident that it will “end the 2009 fiscal year on a high note” primarily because of the addition of new manufacturing contracts and the emergence of its pharmaceutical business.

Pharmaceutical revenues for the nine months ended December 31st were $1.1 million, a 2722 percent increase over the same period in 2007.

CFO, Carol Dore-Falcone stated that the company hopes to “achieve break even on a cash basis in the final quarter of 2009 fiscal year ending March 31, 2009, and to see continued improvements in our financial results thereafter.”

Earlier this year, the company announced the sale of its majority ownership in its ovarian cancer business for about $2.5 million in cash, and a minority stake in the business, allowing the company to strengthen its financial position and ease “the burden of funding our ovarian cancer business segment,” Taneja said. GeoPharma will still remain a significant partner in the business, with a 40 percent stake.

GeoPharma has three main market segments:

  • Specialty Pharma, which specializes in the formulation of generic drugs for human and veterinary usage and the development of medical devices used by oncologists and other medical professionals.
  • Manufacturing, which manufactures generic drugs nutraceuticals, cosmetics and functional food products
  • Distribution, which packages and distributes the company’s products

In September 2008, Green Coast Capital issued a 12-month price target of $5.00 on GORX, citing the company’s well-defined growth strategy, and FDA approval of its new Largo, FL Cephalosporin facility for the production of the antibiotic, Cephalexin.

Green Coast’s valuation was based on applying a standard 5x gross profit valuation multiple to the company’s current fiscal year gross profit forecast of $20.6 million, and subtracting the company’s current debt of $26.7 million.